Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00832767 · ClinicalTrials.gov registry record · NA
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
A NA study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT00832767 is a NA study that has completed, run by Medtronic - MITG. The registered enrollment target is 202 participants.
The verdict
NCT00832767, a NA study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
The objectives of this trial are: 1. to assess the feasibility and safety of performing SILS™ Port Laparoscopic Cholecystectomy 2. monitor and compare the outcomes of SILS™ Port Laparoscopic Cholecystectomy versus 4PLC to objectively document the scientific merit and the perceived advantages of SILS™ Port Laparoscopic Cholecystectomy.
Interventions
- PROCEDURE SILS™ port laparoscopic cholecystectomy
- PROCEDURE Four Port Laparoscopic Cholecystectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00832767
The ClinicalTrials.gov registry entry for NCT00832767 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SILS™ port laparoscopic cholecystectomy is the first listed.
NCT00832767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00832767 about?
NCT00832767 is a clinical study titled "SILS™ Port Laparoscopic Cholecystectomy Post Market Study". The objectives of this trial are: 1. to assess the feasibility and safety of performing SILS™ Port Laparoscopic Cholecystectomy 2. monitor and compare the outcomes of SILS™ Port Laparoscopic Cholecystectomy versus 4PLC to objectively document the scientific merit and the perceived advantages of SIL...
What is the current status of trial NCT00832767?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2009-04. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00832767?
The interventions under investigation include: SILS™ port laparoscopic cholecystectomy (PROCEDURE), Four Port Laparoscopic Cholecystectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00832767?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.